Neuropsychiatric Disease and Treatment (Mar 2023)
Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
Abstract
Céline Wessa,1,2 Manuel Morrens,1,2 Livia J De Picker1,2 1Scientific Initiative for Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Hospital Campus Duffel, Duffel, Belgium; 2Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, BelgiumCorrespondence: Céline Wessa, Email [email protected]